the aid library

LIST OPTIONS

Filter

1076

Sort by:

Direction:

Download (645)

View PDF (1230)

Disaster Management Strategic Framework 2010-2015

Nepal Red Cross Society (2014) C1

Download (279)

View PDF (746)

A framework for assessing the performance of health systems

Christopher J.L. Murray1 & Julio Frenk World Health Organization (WHO) (2000)

Bulletin of the World Health Organization, 2000, 78 (6)

Download (609)

View PDF (1244)

Managing stress in humanitarian workers
recommended

Antares Foundation (2012) C1

Guidelines for good practice. 3rd edition The Guidelines for Good Practice are intended to help organizations define their own needs in relation to stress management and develop their own staff care system. The process will be different for each organization. National and international agencies, bi... more

Download (750)

View PDF (1200)

Adult and Adolescent Antiretroviral Therapy Protocols

Ministry of Health, Zambia (2010) C1

Download (650)

View PDF (836)

Evaluation of a Mental Health Training Course for Primary Health Care Workers in Ogun State, South West, Nigeria

Adebowale T., Umukoro O., Gater R., et al. Journal of Psychiatry (2014) CC

Download (344)

View PDF (801)

Instructions for Completing Suspected Adverse Event Reporting Form

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2014) C1

Download (1009)

View PDF (2109)

Emergency Plan of Action (EPoA) Senegal: Ebola Virus Disease

International Federation of Red Cross and Red Crescent Societies; Canadian Red Cross (2014)

Download (538)

View PDF (872)

Adult and Adolescent Antiretroviral Therapy Protocols 2010

Ministry of Health, Zambia (2010) C_WHO

Download (214)

View PDF (233)

CONSENSUS DOCUMENT FOR MANAGEMENT OF TONGUE CANCER

Indian Consensus of Medical Research (2014) C1

Prepared as an outcome of ICMR Subcommittee on Tongue Cancer | This Consensus Document on Management of Tongue Cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interw... more

Download (1305)

View PDF (1741)

Package for Emergency Resuscitation and Intensive Care Unit

World Health Organization WHO (2003) C_WHO

Download (1075)

View PDF (1293)

Guidelines for Asthma Management in Kenya

Ministry of Public Health and Sanitation Kenya (2011) C1

Download (311)

View PDF (305)

Guidelines on the Safety and Vigilance of Medical Products and Health Technologies

Ministry of Health, Kenya (2020) C1

Download (146)

View PDF (212)

If not now, when? Keeping promises to older people affected by humanitarian crises. Summary

HelpAge (2020) CC

A new report from aid agencies Age International and HelpAge International, If not now, when? criticises the humanitarian sector for its failure to address the needs of older people in emergencies. This failure contravenes several international commitments made in recent years and flies in the face ... more

Download (172)

View PDF (198)

WHO recommendations on outpatient settings for induction of labour

World Health Organization WHO (2022) C_WHO

The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this inclu... more

Download (124)

View PDF (180)

Research Terms of Reference: Cholera Surveillance at Health Facilities in Northeast Syria, SYR2214 (Nov 2022, Version 1)
recommended

REACH: Informing more effective humanitarian action (2022) CC

Since late August 2022, cases of severe acute watery diarrhoea have been increasingly reported across Syria, concentrated particularly along the Euphrates river. These were later confirmed to be cholera cases.3 Cholera is a disease caused by bacteria that can be found in faeces, and spreads throug... more

Download (94)

View PDF (367)

Global report on neglected tropical diseases 2023

World Health Organisation (WHO) (2023) C_WHO

The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs). This work is described in the NTD ... more

Download (205)

View PDF (168)

Global oral health status report: towards universal health coverage for oral health by 2030: regional summary of the Western Pacific Region

World Health Organisation (WHO) (2023) C_WHO

This regional summary draws on the WHO Global oral health status report (2), published in 2022, which provides a comprehensive overview of the global oral disease burden, the global health importance of oral health and the impact of oral diseases over the life course. The summary focuses on the ... more

Download (210)

View PDF (189)

Obstetric Fistula Strategic Plan 2022 - 2026

Government of Zambia World Health Organisation (WHO) Regional Office Africa (2023) C_WHO

Globally, over two million women live with obstetric fistula with the majority of the cases being from Africa. In low-resource settings such as Zambia, obstetric fistula (OF) is a visible indicator of gaps in maternal health care resulting in failure to provide adequate, accessible and quality m... more

Download (245)

View PDF (330)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (43)

View PDF (29)

Operational guidance on the use of yellow fever assays in the context of surveillance

World Health Organization WHO (2023) C_WHO

This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm... more

Managing stress in humanitarian workers recommended

Research Terms of Reference: Cholera Surveillance at Health Facilities in Northeast Syria, SYR2214 (Nov 2022, Version 1) recommended

Managing stress in humanitarian workers
recommended

Research Terms of Reference: Cholera Surveillance at Health Facilities in Northeast Syria, SYR2214 (Nov 2022, Version 1)
recommended